MedPath

青海天润药业有限公司

Ownership
-
Established
2000-08-01
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

NMPA:11

Drug Approvals

接骨续筋胶囊

Approval Number
国药准字Z20090643
Approval Date
Mar 18, 2024
NMPA

十四味羚牛角丸

Approval Number
国药准字Z63020241
Approval Date
Mar 20, 2020
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H63020134
Approval Date
Mar 20, 2020
NMPA

Aspirin Tablets

Product Name
阿司匹林片
Approval Number
国药准字H63020132
Approval Date
Mar 20, 2020
NMPA

Albendazole Tablets

Product Name
阿苯达唑片
Approval Number
国药准字H63020131
Approval Date
Mar 20, 2020
NMPA

Ranitidine Hydrochloride Capsules

Product Name
盐酸雷尼替丁胶囊
Approval Number
国药准字H63020138
Approval Date
Mar 20, 2020
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H63020137
Approval Date
Mar 20, 2020
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H63020136
Approval Date
Mar 20, 2020
NMPA

Naproxen Capsules

Product Name
萘普生胶囊
Approval Number
国药准字H63020139
Approval Date
Mar 20, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H63020133
Approval Date
Mar 20, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.